Abstract
This article describes the concept of probiotics for patients with irritable bowel syndrome to target functionally active bacteria predominantly belonging to the Clostridia and Bacteroidia, which play a key role in maintaining the balance of the gut microbiota.
Original language | English |
---|---|
Article number | e14805 |
Journal | Neurogastroenterology and Motility |
Volume | 36 |
Issue number | 8 |
Early online date | 23 Apr 2024 |
DOIs | |
Publication status | Published - Aug 2024 |
Field of Science*
- 3.2 Clinical medicine
Publication Type*
- 1.1. Scientific article indexed in Web of Science and/or Scopus database